EXAGEN INC
For the period ended Dec 31, 2023. Filed Mar 18, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 18, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| EXAGEN INC. | ||
| Date: March 18, 2024 | by: | /s/ John Aballi |
|---|---|---|
| John Aballi | ||
| President and Chief Executive Officer | ||
| (Principal Executive Officer) | ||
Power of Attorney
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints John Aballi and Kamal Adawi as his or her true and lawful attorneys-in-fact, and each of them, with full power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact, and either of them, or his or their substitute or substitutes may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ John Aballi | President, Chief Executive Officer and Director | March 18, 2024 |
| John Aballi | (Principal Executive Officer) | |
| /s/ Kamal Adawi | Chief Financial Officer and Corporate Secretary | March 18, 2024 |
| Kamal Adawi | (Principal Financial and Accounting Officer) | |
| /s/ Tina S. Nova, Ph.D. | Executive Chairman of the Board | March 18, 2024 |
| Tina S. Nova, Ph.D. | ||
| /s/ Brian Birk | Director | March 18, 2024 |
| Brian Birk | ||
| /s/ Ana Hooker | Director | March 18, 2024 |
| Ana Hooker | ||
| /s/ Wendy S. Johnson | Director | March 18, 2024 |
| Wendy S. Johnson | ||
| /s/ Paul Kim | Director | March 18, 2024 |
| Paul Kim | ||
| /s/ Ebetuel Pallares, Ph.D. | Director | March 18, 2024 |
| Ebetuel Pallares, Ph.D. | ||
| /s/ Bruce C. Robertson, Ph.D. | Director | March 18, 2024 |
| Bruce C. Robertson, Ph.D. | ||
| /s/ Frank Stokes | Director | March 18, 2024 |
| Frank Stokes | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.